贺秀华. 腹型肥胖患者体脂分布与代谢综合征及冠状动脉病变的关系[J]. 心脏杂志, 2018, 30(1): 40-43.
    引用本文: 贺秀华. 腹型肥胖患者体脂分布与代谢综合征及冠状动脉病变的关系[J]. 心脏杂志, 2018, 30(1): 40-43.
    Fat distribution in abdominal obesity and its relationship to metabolic syndrome and coronary artery disease[J]. Chinese Heart Journal, 2018, 30(1): 40-43.
    Citation: Fat distribution in abdominal obesity and its relationship to metabolic syndrome and coronary artery disease[J]. Chinese Heart Journal, 2018, 30(1): 40-43.

    腹型肥胖患者体脂分布与代谢综合征及冠状动脉病变的关系

    Fat distribution in abdominal obesity and its relationship to metabolic syndrome and coronary artery disease

    • 摘要: 目的 探讨腹型肥胖患者各部位脂肪分布与代谢综合征(MS)和冠状动脉病变(CAD)的关系。方法 57例腹型肥胖患者,采用GE64层螺旋CT评估腹部、心脏及冠脉周围脂肪分布情况,超声评估肾脏周围脂肪分布情况,同时测量血生化指标、体质量指数和腰臀比等。结果 ①MS组VAT、肾短轴脂肪面积及Gessini积分显著高于单纯肥胖组〔分别为(2290±601) cc vs.(3024±792) cc;(13.4±1.1) mm2 vs.(18.8±2.2) mm2;(20±3) vs.(46±6);P<0.05,P<0.01〕;多因素Logistic回归分析显示VAT是MS的独立危险因素(OR=1.002,95%CI 1.000-1.003,P<0.05);②Gessini评分>80分组WHR、MS异常代谢组分个数、糖尿病比例、CYS-C、EAT、冠脉周围脂肪厚度均显著高于Gessini评分40~80分组及Gessini评分<40分组〔分别为(1.10±0.01) vs.(0.96±0.01)、(0.96±0.01);(4.38±0.38) vs.(3.35±0.27)、(2.71±0.27);71% vs. 17%、6%;(1.33±0.21) mg/L vs.(1.03±0.07) mg/L、(0.86±0.04) mg/L;(217±58) cc vs.(201±18) cc、(129±18) cc;(17.0±1.2) mm vs.(14.3±0.6) mm、(10.4±0.6) mm;P<0.05,P<0.01〕。多因素逐步回归分析显示,MS异常代谢组分个数、CYS-C、冠脉周围脂肪厚度是影响冠脉病变程度的危险因素。结论 肥胖患者体内不同部位的脂肪沉积对其代谢、心血管疾病的作用具有差异性;在明显肥胖患者中,心脏及冠脉周围脂肪分布可能是更重要的心血管危险因子。

       

      Abstract: AIM To describe the characteristics of fat distribution in obesity and to explore its relationship to the occurrence and severity of metabolic disorder and coronary artery diseases. METHODS Fifty-seven patients (43 males and 14 females) with definite abdominal obesity, mean age of 52.44±11.47 yeas were included in this study. Fat accumulation in heart, aorta and abdominal viscera were quantified by 64-slice computer tomography. Peri-renal fat accumulation was measured by ultrasound. Traditional cardiovascular risk factors and metabolic risk factors were also examined. RESULTS VAT, peri-renal fat and Gessini score were significantly larger in patients with metabolic syndrome (MS) than those without [(2290±601) cc versus.(3024±792) cc; (13.4±1.1) mm2 vs.(18.8±2.2) mm2; (20±3) vs.(46±6); P<0.05, P<0.01]. VAT was significantly associated with the pressence of MS by multivariate logistic regression (OR=1.002, 95%CI 1.000-1.003, P<0.05). WHR, number of MS components, diabetes mellitus, CYS-C, EAT and pericoronary adipose tissue in Gessini score>80 group were significantly higher than those in Gessini score 40~80 group and Gessini score<40 group [(1.10±0.01) vs.(0.96±0.01), (0.96±0.01);(4.38±0.38) vs.(3.35±0.27), (2.71±0.27); 71% vs. 17%, 6%; (1.33±0.21) mg/L vs.(1.03±0.07 ) mg/L, (0.86±0.04) mg/L; (217±58) cc vs.(201±18) cc, (129±18) cc; (17.0±1.2) mm vs.(14.3±0.6) mm, (10.4±0.6) mm; P<0.05, P<0.01]. Multivariate stepwise regression analysis showed a significant relationship between Gessini score and MS, pericoronary adipose tissue thickness and cystatin. CONCLUSION Varying locations of body fat distribution play different roles in obesity-related metabolic cardiovascular disease in abdominal obesity.

       

    /

    返回文章
    返回